Molecular formal concept analysis for compound selectivity profiling in biologically annotated databases

Journal of Chemical Information and Modeling

Volumn 49, Issue 6, 2009, Pages 1359-1368

  Lounkine, Eugen ^a   Stumpfe, Dagmar ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; INFORMATION ANALYSIS; INFORMATION THEORY;

ANNOTATED DATABASE; ARBITRARY NUMBER; COMPOUND SELECTIVITY; DRUG CANDIDATES; MULTIPLE TARGETS; SEQUENTIAL MANNERS; STRUCTURE-SELECTIVITY RELATIONSHIP; TARGETS OF INTEREST;

FORMAL CONCEPT ANALYSIS;

CASPASE; ENZYME INHIBITOR; INOSINATE DEHYDROGENASE;

ARTICLE; DRUG ANTAGONISM; DRUG SCREENING; ENZYME SPECIFICITY; FACTUAL DATABASE; METABOLISM; METHODOLOGY;

CASPASES; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; IMP DEHYDROGENASE; SUBSTRATE SPECIFICITY;

EID: 67650088856     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci900095v     Document Type: Article

References (36)

1. Bajorath, J. Integration of Virtual and High-Throughput Screening. Nat. Rev. Drug Discovery 2002, 1, 882-894.
2. Bajorath, J. Computational Analysis of Ligand Relationships within Target Families. Curr. Opin. Chem. Biol. 2008, 12, 352-358.
3. Bredel, M.; Jacoby, E. Chemogenomics: An Emerging Strategy for Rapid Target and Drug Discovery. Nat. Rev. Genet. 2004, 5, 262-275.
4. Rognan, D. Chemogenomic Approaches to Rational Drug Design. Br. J. Pharmacol. 2007, 152, 38-52.
5. Kauvar, L. M.; Higgins, D. L.; Villar, H. O.; Sportsman, J. R.; Engqvist-Goldstein, A.; Bukar, R.; Bauer, K. E.; Dilley, H.; Rocke, D. M. Predicting Ligand Binding to Proteins by Affinity Fingerprinting. Chem. Biol. 1995, 2, 107-118.
6. Fabian, M. A.; Biggs, W. H.; Treiber, D. K.; Atteridge, C. E.; Azimioara, M. D.; Benedetti, M. G.; Carter, T. A.; Ciceri, P.; Edeen, P. T.; Floyd, M.; Ford, J. M.; Galvin, M.; Gerlach, J. L.; Grotzfeld, R. M.; Herrgard, S.; Insko, D. E.; Insko, M. A.; Lai, A. G.; Lélias, J.; Mehta, S. A.; Milanov, Z. V.; Velasco, A. M.; Wodicka, L. M.; Patel, H. K.; Zarrinkar, P. P.; Lockhart, D. J. A Small Molecule-Kinase Interaction Map for Clinical Kinase Inhibitors. Nat. Biotechnol. 2005, 23, 329-336.
7. Mestres, J.; Martin-Couce, L.; Gregori-Puigjane, E.; Cases, M.; Boyer, S. Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling. J. Chem. Inf. Model. 2006, 46, 2725-2736.
8. Paolini, G. V.; Shapland, R. H. B.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global Mapping of Pharmacological Space. Nat. Biotechnol. 2006, 24, 805-815.
9. Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.; Irwin, J. J.; Shoichet, B. K. Relating Protein Pharmacology by Ligand Chemistry. Nat. Biotechnol. 2007, 25, 197-206.
10. Yildirim, M. A.; Goh, K.; Cusick, M. E.; Barabási, A.; Vidal, M. Drug-Target Network. Nat. Biotechnol. 2007, 25, 1119-1126.
11. Nidhi; Glick, M.; Davies, J. W.; Jenkins, J. L. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases. J. Chem. Inf. Model. 2006, 46, 1124-1233.
12. Schnur, D. M.; Hermsmeier, M. A.; Tebben, A. J. Are Target-Family- Privileged Substructures Truly Privileged. J. Med. Chem. 2006, 49, 2000-2009.
13. Aronov, A. M.; McClain, B.; Moody, C. S.; Murcko, M. A. Kinase-Likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology. J. Med. Chem. 2008, 51, 1214-1222.
14. Batista, J.; Bajorath, J. Mining of Randomly Generated Molecular Fragment Populations Uncovers Activity-Specific Fragment Hierarchies. J. Chem. Inf. Model. 2007, 47, 1405-1413.
15. Lounkine, E.; Auer, J.; Bajorath, J. Formal Concept Analysis for the Identification of Molecular Fragment Combinations Specific for Active and Highly Potent Compounds. J. Med. Chem. 2008, 51, 5342-5348.
16. Priss, U. Formal Concept Analysis in Information Science. Annu. Rev. Inform. Sci. Technol. 2006, 40, 521-543.
17. Frye, S. V. Structure-Activity Relationship Homology (SARAH): a Conceptual Framework for Drug Discovery in the Genomic Era. Chem. Biol. 1999, 6, R3-R7.
18. Schuffenhauer, A.; Floersheim, P.; Acklin, P.; Jacoby, E. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins. J. Chem. Inf. Comput. Sci. 2003, 43, 391-405.
19. Xia, X.; Maliski, E. G.; Gallant, P.; Rogers, D. Classification of Kinase Inhibitors Using a Bayesian Model. J. Med. Chem. 2004, 47, 4463-4470.
20. Stumpfe, D.; Ahmed, H. E. A.; Vogt, I.; Bajorath, J. Methods for Computer-Aided Chemical Biology. Part 1: Design of a Benchmark System for the Evaluation of Compound Selectivity. Chem. Biol. Drug. Des. 2007, 70, 182-194.
21. Vogt, I.; Stumpfe, D.; Ahmed, H. E. A.; Bajorath, J. Methods for Computer-Aided Chemical Biology. Part 2: Evaluation of Compound Selectivity Using 2D Molecular Fingerprints. Chem. Biol. Drug. Des. 2007, 70, 195-205.
22. Stumpfe, D.; Geppert, H.; Bajorath, J. Methods for Computer-Aided Chemical Biology. Part 3: Analysis of Structure-Selectivity Relationships Through Single- or Dual-Step Selectivity Searching and Bayesian Classification. Chem. Biol. Drug. Des. 2008, 71, 518-528.
23. Ahmed, H. E. A.; Geppert, H.; Stumpfe, D.; Lounkine, E.; Bajorath, J. Methods for Computer-Aided Chemical Biology. Part 4: Selectivity Searching for Ion Channel Ligands and Mapping of Molecular Fragments as Selectivity Markers. Chem. Biol. Drug. Des. 2009, 73, 273-282.
24. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R. N.; Gilson, M. K. Binding DB: a Web-Accessible Database of Experimentally Determined Protein-Ligand Binding Affinities. Nucleic Acids Res. 2007, 35, D198-D201.
25. Molecular Operating Environment (MOE) 2007.09; Chemical Computing Group, Inc.: Montreal, Canada, 2007.
26. Haberland, M.; Montgomery, R. L.; Olson, E. N. The Many Roles of Histone Deacetylases in Development and Physiology: Implications for Disease and Therapy. Nat. Rev. Genet. 2009, 10, 32-42.
27. Giembycz, M. A. Cilomilast: A Second Generation Phosphodiesterase 4 Inhibitor for Asthma and Chronic Obstructive Pulmonary Disease. Expert Opin. Invest. Drugs 2001, 10, 1361-1379.
28. Sanford, M.; Keating, G. M. Enteric-Coated Mycophenolate Sodium: A Review of its Use in the Prevention of Renal Transplant Rejection. Drugs 2008, 68, 2505-2533.
29. Natori, S.; Higuchi, H.; Contreras, P.; Gores, G. J. The Caspase Inhibitor IDN-6556 Prevents Caspase Activation and Apoptosis in Sinusoidal Endothelial Cells During Liver Preservation Injury. Liver Transplant 2003, 9, 278-284.
30. Han, J. W.; Ahn, S. H.; Park, S. H.; Wang, S. Y.; Bae, G. U.; Seo, D. W.; Kwon, H. K.; Hong, S.; Lee, H. Y.; Lee, Y. W.; Lee, H. W. Apicidin, a Histone Deacetylase Inhibitor, Inhibits Proliferation of Tumor Cells via Induction of p21WAF1/Cip1 and Gelsolin. Cancer Res. 2000, 60, 6068-6064.
31. Kips, J. C.; Joos, G. F.; Peleman, R. A.; Pauwels, R. A. The Effect of Zardaverine, an Inhibitor of Phosphodiesterase Isoenzymes III and IV, on Endotoxin-Induced Airway Changes in Rats. Clin. Exp. Allergy 1993, 23, 518-523.
32. Spina, D. PDE4 Inhibitors: Current Status. Br. J. Pharmacol. 2008, 155, 308-315.
33. Heaslip, R. J.; Lombardo, L. J.; Golankiewicz, J. M.; Ilsemann, B. A.; Evans, D. Y.; Sickels, B. D.; Mudrick, J. K.; Bagli, J.; Weichman, B. M. Phosphodiesterase-IV Inhibition, Respiratory Muscle Relaxation and Bronchodilation by WAY-PDA-641. J. Pharmacol. Exp. Ther. 1994, 268, 888-896.
34. Dinter, H.; Tse, J.; Halks-Miller, M.; Asarnow, D.; Onuffer, J.; Faulds, D.; Mitrovic, B.; Kirsch, G.; Laurent, H.; Esperling, P.; Seidelmann, D.; Ottow, E.; Schneider, H.; Tuohy, V. K.; Wachtel, H.; Perez, H. D. The Type IV Phosphodiesterase Specific Inhibitor Mesopram Inhibits Experimental Autoimmune Encephalomyelitis in Rodents. J. Neuroimmunol. 2000, 108, 136-146.
35. Wachtel, H. Potential Antidepressant Activity of Rolipram and other Selective Cyclic Adenosine 3′,5′-Monophosphate Phosphodiesterase Inhibitors. Neuropharmacology 1983, 22, 267-272.
36. Sommer, N.; Löschmann, P. A.; Northoff, G. H.; Weller, M.; Steinbrecher, A.; Steinbach, J. P.; Lichtenfels, R.; Meyermann, R.; Riethmüller, A.; Fontana, A. The Antidepressant Rolipram Suppresses Cytokine Production and Prevents Autoimmune Encephalomyelitis. Nat. Med. 1995, 1, 244-248.